NUF2 and tumor prognosis

doi:10.3760/cma.j.cn371439-20211025-00027

Abstract

Abstract:

NUF2 is responsible for the attachment of kinetochore-microtubules and proper chromosome segregation during mitosis. NUF2 is highly expressed in hepatocellular carcinoma, pancreatic cancer, esophageal cancer, non-small cell lung cancer, breast cancer and other tumor tissues and cells, and can be used as prognostic markers. Further clarifying the relationship between NUF2 and tumor prognosis can provide help for the application of NUF2 in prognostic assessment of cancers.

Key words: Neoplasms, Prognosis, NUF2

Ren Meng, Yang Lu, Zhao Xiaoting, Yue Wentao. NUF2 and tumor prognosis[J]. Journal of International Oncology, 2022, 49(3): 164-167.

References 27

[1]	Ustinov NB, Korshunova AV, Gudimchuk NB. Protein complex NDC80: properties, functions, and possible role in pathophysiology of cell division[J]. Biochemistry (Mosc), 2020, 85(4):448-462. DOI: 10.1134/S0006297920040057. doi: 10.1134/S0006297920040057
[2]	Subramonian D, Chen TA, Paolini N, et al. Poly-SUMO-2/3 chain modification of Nuf2 facilitates CENP-E kinetochore localization and chromosome congression during mitosis[J]. Cell Cycle, 2021, 20(9):855-873. DOI: 10.1080/15384101.2021.1907509. doi: 10.1080/15384101.2021.1907509
[3]	Uehara DT, Mitsubuchi H, Inazawa J. A missense variant in NUF2, a component of the kinetochore NDC80 complex, causes impaired chromosome segregation and aneuploidy associated with microcephaly and short stature[J]. Hum Genet, 2021, 140(7):1047-1060. DOI: 10.1007/s00439-021-02273-4. doi: 10.1007/s00439-021-02273-4
[4]	魏永健, 胡进静, 李汛. CDCA8与肿瘤发生发展及干细胞干性维持的关系[J]. 国际肿瘤学杂志, 2021, 48(4):216-219. DOI: 10.3760/cma.j.cn371439-20201012-00043. doi: 10.3760/cma.j.cn371439-20201012-00043
[5]	Jiang X, Jiang Y, Luo S, et al. Correlation of NUF2 overexpression with poorer patient survival in multiple cancers[J]. Cancer Res Treat, 2021, 53(4):944-961. DOI: 10.4143/crt.2020.466. doi: 10.4143/crt.2020.466
[6]	Lv S, Xu W, Zhang Y, et al. NUF2 as an anticancer therapeutic target and prognostic factor in breast cancer[J]. Int J Oncol, 2020, 57(6):1358-1367. DOI: 10.3892/ijo.2020.5141. doi: 10.3892/ijo.2020.5141
[7]	Wang Y, Tan PY, Handoko YA, et al. NUF2 is a valuable prognostic biomarker to predict early recurrence of hepatocellular carcinoma after surgical resection[J]. Int J Cancer, 2019, 145(3):662-670. DOI: 10.1002/ijc.32134. doi: 10.1002/ijc.32134 pmid: 30653265
[8]	Guo L, Wang Z, Du Y, et al. Random-forest algorithm based biomarkers in predicting prognosis in the patients with hepatocellular carcinoma[J]. Cancer Cell Int, 2020, 20:251. DOI: 10.1186/s12935-020-01274-z. doi: 10.1186/s12935-020-01274-z
[9]	Jacobs NR, Norton PA. Role of chromosome 1q copy number variation in hepatocellular carcinoma[J]. World J Hepatol, 2021, 13(6):662-672. DOI: 10.4254/wjh.v13.i6.662. doi: 10.4254/wjh.v13.i6.662
[10]	Zhang Y, Tang Y, Guo C, et al. Integrative analysis identifies key mRNA biomarkers for diagnosis, prognosis, and therapeutic targets of HCV-associated hepatocellular carcinoma[J]. Aging (Albany NY), 2021, 13(9):12865-12895. DOI: 10.18632/aging.202957. doi: 10.18632/aging.202957
[11]	Xie X, Jiang S, Li X. Nuf2 is a prognostic-related biomarker and correlated with immune infiltrates in hepatocellular carcinoma[J]. Front Oncol, 2021, 11:621373. DOI: 10.3389/fonc.2021.621373. doi: 10.3389/fonc.2021.621373
[12]	Cassetta L, Fragkogianni S, Sims AH, et al. Human tumor-associated macrophage and monocyte transcriptional landscapes reveal cancer-specific reprogramming, biomarkers, and therapeutic targets[J]. Cancer Cell, 2019, 35(4): 588-602. e10. DOI: 10.1016/j.ccell.2019.02.009. doi: S1535-6108(19)30104-7 pmid: 30930117
[13]	Xing C, Wang Z, Zhu Y, et al. Integrate analysis of the promote function of cell division cycle-associated protein family to pancreatic adenocarcinoma[J]. Int J Med Sci, 2021, 18(3):672-684. DOI: 10.7150/ijms.53243. doi: 10.7150/ijms.53243
[14]	Wong CH, Lou UK, Li Y, et al. CircFOXK2 promotes growth and metastasis of pancreatic ductal adenocarcinoma by complexing with RNA-binding proteins and sponging miR-942[J]. Cancer Res, 2020, 80(11):2138-2149. DOI: 10.1158/0008-5472.CAN-19-3268. doi: 10.1158/0008-5472.CAN-19-3268 pmid: 32217695
[15]	Zheng L, Li L, Xie J, et al. Six novel biomarkers for diagnosis and prognosis of esophageal squamous cell carcinoma: validated by scRNA-seq and qPCR[J]. J Cancer, 2021, 12(3):899-911. DOI: 10.7150/jca.50443. doi: 10.7150/jca.50443
[16]	Chen M, Li S, Liang Y, et al. Integrative multi-omics analysis of identified NUF2 as a candidate oncogene correlates with poor prognosis and immune infiltration in non-small cell lung cancer[J]. Front Oncol, 2021, 11:656509. DOI: 10.3389/fonc.2021.656509. doi: 10.3389/fonc.2021.656509
[17]	Sun ZY, Wang W, Gao H, et al. Potential therapeutic targets of the nuclear division cycle 80 (NDC80) complexes genes in lung adenocarcinoma[J]. J Cancer, 2020, 11(10):2921-2934. DOI: 10.7150/jca.41834. doi: 10.7150/jca.41834
[18]	Hitti E, Bakheet T, Al-Souhibani N, et al. Systematic analysis of AU-Rich element expression in cancer reveals common functional clusters regulated by key RNA-binding proteins[J]. Cancer Res, 2016, 76(14):4068-4080. DOI: 10.1158/0008-5472.CAN-15-3110. doi: 10.1158/0008-5472.CAN-15-3110
[19]	Xu W, Wang Y, Wang Y, et al. Screening of differentially expressed genes and identification of NUF2 as a prognostic marker in breast cancer[J]. Int J Mol Med, 2019, 44(2):390-404. DOI: 10.3892/ijmm.2019.4239. doi: 10.3892/ijmm.2019.4239
[20]	Zhai X, Yang Z, Liu X, et al. Identification of NUF2 and FAM83D as potential biomarkers in triple-negative breast cancer[J]. PeerJ, 2020, 8:e9975. DOI: 10.7717/peerj.9975. doi: 10.7717/peerj.9975
[21]	Zhang W, Qiu X, Sun D, et al. Systematic analysis of the clinical relevance of cell division cycle associated family in endometrial carcinoma[J]. J Cancer, 2020, 11(19):5588-5600. DOI: 10.7150/jca.46324. doi: 10.7150/jca.46324
[22]	Tang H, Wu Z, Zhang Y, et al. Identification and function analysis of a five-long noncoding RNA prognostic signature for endometrial cancer patients[J]. DNA Cell Biol, 2019, 38(12):1480-1498. DOI: 10.1089/dna.2019.4944. doi: 10.1089/dna.2019.4944
[23]	Xie X, Lin J, Fan X, et al. LncRNA CDKN2B-AS1 stabilized by IGF2BP3 drives the malignancy of renal clear cell carcinoma through epigenetically activating NUF2 transcription[J]. Cell Death Dis, 2021, 12(2):201. DOI: 10.1038/s41419-021-03489-y. doi: 10.1038/s41419-021-03489-y
[24]	Zhang H, Zou J, Yin Y, et al. Bioinformatic analysis identifies potentially key differentially expressed genes in oncogenesis and progression of clear cell renal cell carcinoma[J]. PeerJ, 2019, 7:e8096. DOI: 10.7717/peerj.8096. doi: 10.7717/peerj.8096
[25]	Shan L, Zhu XL, Zhang Y, et al. Expression and clinical significance of NUF2 in kidney renal clear cell carcinoma[J]. Transl Androl Urol, 2021, 10(9):3628-3637. DOI: 10.21037/tau-21-620. doi: 10.21037/tau-21-620 pmid: 34733658
[26]	Tokuzumi A, Fukushima S, Miyashita A, et al. Cell division cycle-associated protein 1 as a new melanoma-associated antigen[J]. J Dermatol, 2016, 43(12):1399-1405. DOI: 10.1111/1346-8138.13436. doi: 10.1111/1346-8138.13436
[27]	Huang C, Chen L, Savage SR, et al. Proteogenomic insights into the biology and treatment of HPV-negative head and neck squamous cell carcinoma[J]. Cancer Cell, 2021, 39(3): 361-379. e16. DOI: 10.1016/j.ccell.2020.12.007. doi: 10.1016/j.ccell.2020.12.007 pmid: 33417831